Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDIV × Gemcitabine × Clear all

Phase

Status

Sponsor Class

OTHER 676 INDUSTRY 202 NETWORK 65 NIH 63 OTHER_GOV 20 UNKNOWN 3 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Proflavine 2 Microbial Collagenase 2 pegfilgrastim 1 macimorelin 1 Uracil 1 Tegafur 1 Sirolimus 1 Mifepristone 1 Gemcitabine 1 Everolimus 1 Darbepoetin alfa 1 Corlux 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429973 2015-04-29

GEIS-29

Broto, Javier Martín, M.D.

Phase 2 Completed

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡